Merck (MRK) Equity Income (2009 - 2014)
Merck (MRK) reported Equity Income of $16 million for Q4 2014, down 69.8% from $53 million a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Equity Income (2009 - 2014) Analysis & Trends
For FY2014, Merck posted Equity Income of $257 million, down 36.4% from FY2013.
- Equity Income has a four-year compound annual growth rate of -18.7% (FY2010 to FY2014).
- By year, Equity Income came in at $404 million in FY2013 (-37.1%), $642 million in FY2012 (+5.2%), $610 million in FY2011 (+3.9%) and $587 million in FY2010.
- The Q4 2014 figure ranks as the lowest quarterly Equity Income in data going back to Q2 2009.
- Year over year, Equity Income has now declined in each of the last seven quarters, with an average decline of 35.5% over the last eight quarters.
- The high point for year-over-year Equity Income in five years was Q1 2013 (growth of 20.9%); the low point was Q4 2013 (a decline of 77.2%).
- Per Business Quant data, the three quarters before Q4 2014 came in at $24 million (Q3 2014), $92 million (Q2 2014) and $124 million (Q1 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | - |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | - |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | - |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 16.00 Mn |
| Sep 30, 2014 | 24.00 Mn |
| Jun 30, 2014 | 92.00 Mn |
| Mar 31, 2014 | 124.00 Mn |
| Dec 31, 2013 | 53.00 Mn |
| Sep 30, 2013 | 102.00 Mn |
| Jun 30, 2013 | 116.00 Mn |
| Mar 31, 2013 | 133.00 Mn |
| Dec 31, 2012 | 232.00 Mn |
| Sep 30, 2012 | 158.00 Mn |
| Jun 30, 2012 | 142.00 Mn |
| Mar 31, 2012 | 110.00 Mn |
| Dec 31, 2011 | 256.00 Mn |
| Sep 30, 2011 | 161.00 Mn |
| Sep 30, 2009 | 387.00 Mn |
| Jun 30, 2009 | 370.00 Mn |
API Access
Merck Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();